Invention Grant
- Patent Title: Compounds and method for treatment of HIV
-
Application No.: US15209231Application Date: 2016-07-13
-
Publication No.: US09624220B2Publication Date: 2017-04-18
- Inventor: Wayne Danter , Clinton Threlfall , Sylvain Guizzetti , Julien Marin
- Applicant: Critical Outcome Technologies Inc.
- Applicant Address: CA London
- Assignee: Critical Outcome Technologies Inc.
- Current Assignee: Critical Outcome Technologies Inc.
- Current Assignee Address: CA London
- Agency: Dilworth IP LLC
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D239/36 ; C07D239/40 ; C07D239/42 ; C07D413/04 ; C07D239/47 ; C07D239/557 ; C07D239/56 ; C07D487/04

Abstract:
The invention relates to a compound of Formulae I and/or II: and/or a pharmaceutically-acceptable salt, hydrate, solvate, tautomer, optical isomer, E-isomer, Z-isomer, or combination thereof; X is selected from Se, N—OH, NH, NO2, CN, N—CN, N═O, O or S, and the remaining substituents are described herein; and a composition thereof. The invention also relates to a method of administration thereof; and use thereof to treat HIV.
Public/Granted literature
- US20160333010A1 COMPOUNDS AND METHOD FOR TREATMENT OF HIV Public/Granted day:2016-11-17
Information query